Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1972957

Cover Image

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1972957

Growth Factors Market Insights, Competitive Landscape, and Market Forecast - 2033

PUBLISHED:
PAGES: 200 Pages
DELIVERY TIME: 2-5 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4995
Unprintable PDF & Excel (Multi User License upto 5 users)
USD 8495
Printable PDF & Excel (Enterprise License above 5 users)
USD 10600

Add to Cart

Description

Table of Contents

The global Growth Factors Market is anticipated to grow significantly, rising from $2.4 billion in 2026 to $3.9 billion by 2033, at a robust compound annual growth rate (CAGR) of 5.7%. This growth is primarily driven by the increasing adoption of growth factors in biotechnology, pharmaceutical research, and regenerative medicine, alongside the rising prevalence of chronic diseases and cancer worldwide.

Market Overview

Growth factors are naturally occurring proteins that regulate cellular growth, proliferation, and differentiation. They play a vital role in wound healing, tissue regeneration, and targeted therapeutics, making them essential tools in modern biomedical research and clinical applications. Their versatility in oncology, hematology, and regenerative medicine has driven widespread adoption across research and therapeutic pipelines.

Technological advancements, including recombinant DNA technology and protein engineering, have enabled the production of high-purity growth factors, improving their efficacy and availability for research and commercial applications. Increasing investments by pharmaceutical and biotechnology companies in protein-based therapeutics are further driving market expansion.

Market Drivers

Several factors are fueling growth in this market:

  • 1. Rising Chronic Disease and Cancer Incidence: The global increase in cancer, cardiovascular disorders, and diabetes is boosting demand for growth factors as targeted therapies and regenerative solutions gain importance.
  • 2. Advancements in Cell Therapy and Regenerative Medicine: Stem cell research, tissue engineering, and ex-vivo manufacturing require growth factors to enhance cell proliferation and differentiation, driving their adoption in advanced therapeutic applications.
  • 3. Government Support and Funding: Regulatory agencies and governments worldwide are funding biotechnology and regenerative medicine research, promoting the use of growth factors in clinical and research settings.
  • 4. Expansion of Pharmaceutical R&D: Pharmaceutical and biotechnology firms are increasingly investing in protein-based therapeutics, strengthening demand for growth factors across research and drug development programs.

Business Opportunities

The growth factors market presents several lucrative opportunities for manufacturers and investors:

  • Innovative Therapeutics: Growth factors are critical to developing regenerative therapies, cancer treatments, and wound healing products, creating significant opportunities for research and commercialization.
  • Emerging Market Growth: Increasing healthcare infrastructure and research initiatives in Asia Pacific and Latin America provide avenues for market expansion.
  • Strategic Collaborations: Partnerships with research centers, contract research organizations (CROs), and academic institutions can accelerate product development and strengthen market presence.

Regional Analysis

  • North America: Dominates the market due to a strong pharmaceutical and biotechnology ecosystem, well-established research infrastructure, and substantial government funding for advanced therapeutics.
  • Europe: Experiences steady growth driven by high adoption of regenerative therapies, protein-based therapeutics, and supportive regulatory frameworks.
  • Asia Pacific: Projected to grow at the fastest rate, fueled by increasing healthcare expenditure, a growing biotechnology ecosystem, and expanding research initiatives in China, Japan, and India.
  • Latin America: Growth is supported by improving healthcare infrastructure, rising collaborations with global biotech firms, and expanding research capabilities.
  • Middle East & Africa: Though smaller in size, the market is expanding steadily due to increasing awareness of advanced therapies and growing adoption of biotechnology-based solutions.

Key Players

The market is highly competitive, with key players focusing on research, product development, and commercialization. Leading companies include:

  • Lonza Group AG
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Hoffmann-La Roche Ltd.
  • Applied Biological Materials (abm), Inc.
  • Abcam plc
  • GE Healthcare
  • Cell Signaling Technology, Inc.
  • Meridian Bioscience Inc.
  • Sartorius CellGenix GmbH
  • Bio-Techne Corporation
  • Proteintech Group, Inc.
  • Miltenyi Biotec
  • Creative Bioarray
  • Akron Biotech
  • Sino Biological Inc.
  • Repligen Corporation
  • LEADGENE BIOMEDICAL, INC.
  • PeproTech Inc.

These companies are expanding portfolios, investing in R&D, and forming strategic collaborations to develop next-generation growth factors with enhanced stability, specificity, and therapeutic applications.

Market Segmentation

By Product Type:

  • Transforming Growth Factor (TGF)
  • Activin
  • Bone Morphogenetic Proteins (BMPs)
  • TGF-beta Proteins
  • Epidermal Growth Factors (EGFs)
  • Platelet-Derived Growth Factors (PDGFs)
  • Fibroblast Growth Factors (FGFs)
  • Insulin-like Growth Factors (IGFs)
  • Vascular Endothelial Growth Factors (VEGFs)
  • Hepatocyte Growth Factors (HGFs)
  • Tumor Necrosis Factors (TNFs)
  • Interleukins
  • Others

By Application:

  • Oncology
  • Hematology
  • Wound Healing
  • Dermatology
  • Cardiovascular Disease & Diabetes
  • Cell Therapy and Ex-Vivo Manufacturing
  • Others

By End User:

  • Pharmaceutical and Biotechnology Companies
  • Research Centres & Academic Institutes
  • Contract Research Organisations

By Geographic Coverage:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Show more

Table of Contents

1. Executive Summary

  • 1.1. Global Growth Factors Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2026
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Porter's Five Forces Analysis
  • 2.6. Impact of Russia-Ukraine Conflict
  • 2.7. PESTLE Analysis
  • 2.8. Regulatory Analysis
  • 2.9. Price Trend Analysis
    • 2.9.1. Current Prices and Future Projections, 2025-2033
    • 2.9.2. Price Impact Factors

3. Global Growth Factors Market Outlook, 2020-2033

  • 3.1. Global Growth Factors Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
    • 3.1.1. Transforming Growth Factor (TGF)
      • 3.1.1.1. Activin
      • 3.1.1.2. Bone Morphogenetic Proteins (BMPs)
      • 3.1.1.3. TGF-beta Proteins
    • 3.1.2. Epidermal Growth Factors (EGFs)
    • 3.1.3. Platelet-Derived Growth Factors (PDGFs)
    • 3.1.4. Fibroblast Growth Factors (FGFs)
    • 3.1.5. Insulin-like Growth Factors (IGFs)
    • 3.1.6. Vascular Endothelial Growth Factors (VEGFs)
    • 3.1.7. Hepatocyte Growth Factors (HGFs)
    • 3.1.8. Tumor Necrosis Factors (TNFs)
    • 3.1.9. Interleukins
    • 3.1.10. Others
  • 3.2. Global Growth Factors Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 3.2.1. Oncology
    • 3.2.2. Hematology
    • 3.2.3. Wound Healing
    • 3.2.4. Dermatology
    • 3.2.5. Cardiovascular Disease & Diabetes
    • 3.2.6. Cell Therapy and Ex-Vivo Manufacturing
    • 3.2.7. Others
  • 3.3. Global Growth Factors Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 3.3.1. Pharmaceutical and Biotechnology Companies
    • 3.3.2. Research Centres & Academic Institutes
    • 3.3.3. Contract Research Organisations
  • 3.4. Global Growth Factors Market Outlook, by Region, Value (US$ Bn), 2020-2033
    • 3.4.1. North America
    • 3.4.2. Europe
    • 3.4.3. Asia Pacific
    • 3.4.4. Latin America
    • 3.4.5. Middle East & Africa

4. North America Growth Factors Market Outlook, 2020-2033

  • 4.1. North America Growth Factors Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
    • 4.1.1. Transforming Growth Factor (TGF)
      • 4.1.1.1. Activin
      • 4.1.1.2. Bone Morphogenetic Proteins (BMPs)
      • 4.1.1.3. TGF-beta Proteins
    • 4.1.2. Epidermal Growth Factors (EGFs)
    • 4.1.3. Platelet-Derived Growth Factors (PDGFs)
    • 4.1.4. Fibroblast Growth Factors (FGFs)
    • 4.1.5. Insulin-like Growth Factors (IGFs)
    • 4.1.6. Vascular Endothelial Growth Factors (VEGFs)
    • 4.1.7. Hepatocyte Growth Factors (HGFs)
    • 4.1.8. Tumor Necrosis Factors (TNFs)
    • 4.1.9. Interleukins
    • 4.1.10. Others
  • 4.2. North America Growth Factors Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 4.2.1. Oncology
    • 4.2.2. Hematology
    • 4.2.3. Wound Healing
    • 4.2.4. Dermatology
    • 4.2.5. Cardiovascular Disease & Diabetes
    • 4.2.6. Cell Therapy and Ex-Vivo Manufacturing
    • 4.2.7. Others
  • 4.3. North America Growth Factors Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 4.3.1. Pharmaceutical and Biotechnology Companies
    • 4.3.2. Research Centres & Academic Institutes
    • 4.3.3. Contract Research Organisations
  • 4.4. North America Growth Factors Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 4.4.1. U.S. Growth Factors Market Outlook, by Product Type, 2020-2033
    • 4.4.2. U.S. Growth Factors Market Outlook, by Application, 2020-2033
    • 4.4.3. U.S. Growth Factors Market Outlook, by End User, 2020-2033
    • 4.4.4. Canada Growth Factors Market Outlook, by Product Type, 2020-2033
    • 4.4.5. Canada Growth Factors Market Outlook, by Application, 2020-2033
    • 4.4.6. Canada Growth Factors Market Outlook, by End User, 2020-2033
  • 4.5. BPS Analysis/Market Attractiveness Analysis

5. Europe Growth Factors Market Outlook, 2020-2033

  • 5.1. Europe Growth Factors Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
    • 5.1.1. Transforming Growth Factor (TGF)
      • 5.1.1.1. Activin
      • 5.1.1.2. Bone Morphogenetic Proteins (BMPs)
      • 5.1.1.3. TGF-beta Proteins
    • 5.1.2. Epidermal Growth Factors (EGFs)
    • 5.1.3. Platelet-Derived Growth Factors (PDGFs)
    • 5.1.4. Fibroblast Growth Factors (FGFs)
    • 5.1.5. Insulin-like Growth Factors (IGFs)
    • 5.1.6. Vascular Endothelial Growth Factors (VEGFs)
    • 5.1.7. Hepatocyte Growth Factors (HGFs)
    • 5.1.8. Tumor Necrosis Factors (TNFs)
    • 5.1.9. Interleukins
    • 5.1.10. Others
  • 5.2. Europe Growth Factors Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 5.2.1. Oncology
    • 5.2.2. Hematology
    • 5.2.3. Wound Healing
    • 5.2.4. Dermatology
    • 5.2.5. Cardiovascular Disease & Diabetes
    • 5.2.6. Cell Therapy and Ex-Vivo Manufacturing
    • 5.2.7. Others
  • 5.3. Europe Growth Factors Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 5.3.1. Pharmaceutical and Biotechnology Companies
    • 5.3.2. Research Centres & Academic Institutes
    • 5.3.3. Contract Research Organisations
  • 5.4. Europe Growth Factors Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 5.4.1. Germany Growth Factors Market Outlook, by Product Type, 2020-2033
    • 5.4.2. Germany Growth Factors Market Outlook, by Application, 2020-2033
    • 5.4.3. Germany Growth Factors Market Outlook, by End User, 2020-2033
    • 5.4.4. Italy Growth Factors Market Outlook, by Product Type, 2020-2033
    • 5.4.5. Italy Growth Factors Market Outlook, by Application, 2020-2033
    • 5.4.6. Italy Growth Factors Market Outlook, by End User, 2020-2033
    • 5.4.7. France Growth Factors Market Outlook, by Product Type, 2020-2033
    • 5.4.8. France Growth Factors Market Outlook, by Application, 2020-2033
    • 5.4.9. France Growth Factors Market Outlook, by End User, 2020-2033
    • 5.4.10. U.K. Growth Factors Market Outlook, by Product Type, 2020-2033
    • 5.4.11. U.K. Growth Factors Market Outlook, by Application, 2020-2033
    • 5.4.12. U.K. Growth Factors Market Outlook, by End User, 2020-2033
    • 5.4.13. Spain Growth Factors Market Outlook, by Product Type, 2020-2033
    • 5.4.14. Spain Growth Factors Market Outlook, by Application, 2020-2033
    • 5.4.15. Spain Growth Factors Market Outlook, by End User, 2020-2033
    • 5.4.16. Russia Growth Factors Market Outlook, by Product Type, 2020-2033
    • 5.4.17. Russia Growth Factors Market Outlook, by Application, 2020-2033
    • 5.4.18. Russia Growth Factors Market Outlook, by End User, 2020-2033
    • 5.4.19. Rest of Europe Growth Factors Market Outlook, by Product Type, 2020-2033
    • 5.4.20. Rest of Europe Growth Factors Market Outlook, by Application, 2020-2033
    • 5.4.21. Rest of Europe Growth Factors Market Outlook, by End User, 2020-2033
  • 5.5. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Growth Factors Market Outlook, 2020-2033

  • 6.1. Asia Pacific Growth Factors Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
    • 6.1.1. Transforming Growth Factor (TGF)
      • 6.1.1.1. Activin
      • 6.1.1.2. Bone Morphogenetic Proteins (BMPs)
      • 6.1.1.3. TGF-beta Proteins
    • 6.1.2. Epidermal Growth Factors (EGFs)
    • 6.1.3. Platelet-Derived Growth Factors (PDGFs)
    • 6.1.4. Fibroblast Growth Factors (FGFs)
    • 6.1.5. Insulin-like Growth Factors (IGFs)
    • 6.1.6. Vascular Endothelial Growth Factors (VEGFs)
    • 6.1.7. Hepatocyte Growth Factors (HGFs)
    • 6.1.8. Tumor Necrosis Factors (TNFs)
    • 6.1.9. Interleukins
    • 6.1.10. Others
  • 6.2. Asia Pacific Growth Factors Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 6.2.1. Oncology
    • 6.2.2. Hematology
    • 6.2.3. Wound Healing
    • 6.2.4. Dermatology
    • 6.2.5. Cardiovascular Disease & Diabetes
    • 6.2.6. Cell Therapy and Ex-Vivo Manufacturing
    • 6.2.7. Others
  • 6.3. Asia Pacific Growth Factors Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 6.3.1. Pharmaceutical and Biotechnology Companies
    • 6.3.2. Research Centres & Academic Institutes
    • 6.3.3. Contract Research Organisations
  • 6.4. Asia Pacific Growth Factors Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 6.4.1. China Growth Factors Market Outlook, by Product Type, 2020-2033
    • 6.4.2. China Growth Factors Market Outlook, by Application, 2020-2033
    • 6.4.3. China Growth Factors Market Outlook, by End User, 2020-2033
    • 6.4.4. Japan Growth Factors Market Outlook, by Product Type, 2020-2033
    • 6.4.5. Japan Growth Factors Market Outlook, by Application, 2020-2033
    • 6.4.6. Japan Growth Factors Market Outlook, by End User, 2020-2033
    • 6.4.7. South Korea Growth Factors Market Outlook, by Product Type, 2020-2033
    • 6.4.8. South Korea Growth Factors Market Outlook, by Application, 2020-2033
    • 6.4.9. South Korea Growth Factors Market Outlook, by End User, 2020-2033
    • 6.4.10. India Growth Factors Market Outlook, by Product Type, 2020-2033
    • 6.4.11. India Growth Factors Market Outlook, by Application, 2020-2033
    • 6.4.12. India Growth Factors Market Outlook, by End User, 2020-2033
    • 6.4.13. Southeast Asia Growth Factors Market Outlook, by Product Type, 2020-2033
    • 6.4.14. Southeast Asia Growth Factors Market Outlook, by Application, 2020-2033
    • 6.4.15. Southeast Asia Growth Factors Market Outlook, by End User, 2020-2033
    • 6.4.16. Rest of SAO Growth Factors Market Outlook, by Product Type, 2020-2033
    • 6.4.17. Rest of SAO Growth Factors Market Outlook, by Application, 2020-2033
    • 6.4.18. Rest of SAO Growth Factors Market Outlook, by End User, 2020-2033
  • 6.5. BPS Analysis/Market Attractiveness Analysis

7. Latin America Growth Factors Market Outlook, 2020-2033

  • 7.1. Latin America Growth Factors Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
    • 7.1.1. Transforming Growth Factor (TGF)
      • 7.1.1.1. Activin
      • 7.1.1.2. Bone Morphogenetic Proteins (BMPs)
      • 7.1.1.3. TGF-beta Proteins
    • 7.1.2. Epidermal Growth Factors (EGFs)
    • 7.1.3. Platelet-Derived Growth Factors (PDGFs)
    • 7.1.4. Fibroblast Growth Factors (FGFs)
    • 7.1.5. Insulin-like Growth Factors (IGFs)
    • 7.1.6. Vascular Endothelial Growth Factors (VEGFs)
    • 7.1.7. Hepatocyte Growth Factors (HGFs)
    • 7.1.8. Tumor Necrosis Factors (TNFs)
    • 7.1.9. Interleukins
    • 7.1.10. Others
  • 7.2. Latin America Growth Factors Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 7.2.1. Oncology
    • 7.2.2. Hematology
    • 7.2.3. Wound Healing
    • 7.2.4. Dermatology
    • 7.2.5. Cardiovascular Disease & Diabetes
    • 7.2.6. Cell Therapy and Ex-Vivo Manufacturing
    • 7.2.7. Others
  • 7.3. Latin America Growth Factors Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 7.3.1. Pharmaceutical and Biotechnology Companies
    • 7.3.2. Research Centres & Academic Institutes
    • 7.3.3. Contract Research Organisations
  • 7.4. Latin America Growth Factors Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 7.4.1. Brazil Growth Factors Market Outlook, by Product Type, 2020-2033
    • 7.4.2. Brazil Growth Factors Market Outlook, by Application, 2020-2033
    • 7.4.3. Brazil Growth Factors Market Outlook, by End User, 2020-2033
    • 7.4.4. Mexico Growth Factors Market Outlook, by Product Type, 2020-2033
    • 7.4.5. Mexico Growth Factors Market Outlook, by Application, 2020-2033
    • 7.4.6. Mexico Growth Factors Market Outlook, by End User, 2020-2033
    • 7.4.7. Argentina Growth Factors Market Outlook, by Product Type, 2020-2033
    • 7.4.8. Argentina Growth Factors Market Outlook, by Application, 2020-2033
    • 7.4.9. Argentina Growth Factors Market Outlook, by End User, 2020-2033
    • 7.4.10. Rest of LATAM Growth Factors Market Outlook, by Product Type, 2020-2033
    • 7.4.11. Rest of LATAM Growth Factors Market Outlook, by Application, 2020-2033
    • 7.4.12. Rest of LATAM Growth Factors Market Outlook, by End User, 2020-2033
  • 7.5. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Growth Factors Market Outlook, 2020-2033

  • 8.1. Middle East & Africa Growth Factors Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
    • 8.1.1. Transforming Growth Factor (TGF)
      • 8.1.1.1. Activin
      • 8.1.1.2. Bone Morphogenetic Proteins (BMPs)
      • 8.1.1.3. TGF-beta Proteins
    • 8.1.2. Epidermal Growth Factors (EGFs)
    • 8.1.3. Platelet-Derived Growth Factors (PDGFs)
    • 8.1.4. Fibroblast Growth Factors (FGFs)
    • 8.1.5. Insulin-like Growth Factors (IGFs)
    • 8.1.6. Vascular Endothelial Growth Factors (VEGFs)
    • 8.1.7. Hepatocyte Growth Factors (HGFs)
    • 8.1.8. Tumor Necrosis Factors (TNFs)
    • 8.1.9. Interleukins
    • 8.1.10. Others
  • 8.2. Middle East & Africa Growth Factors Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 8.2.1. Oncology
    • 8.2.2. Hematology
    • 8.2.3. Wound Healing
    • 8.2.4. Dermatology
    • 8.2.5. Cardiovascular Disease & Diabetes
    • 8.2.6. Cell Therapy and Ex-Vivo Manufacturing
    • 8.2.7. Others
  • 8.3. Middle East & Africa Growth Factors Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 8.3.1. Pharmaceutical and Biotechnology Companies
    • 8.3.2. Research Centres & Academic Institutes
    • 8.3.3. Contract Research Organisations
  • 8.4. Middle East & Africa Growth Factors Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 8.4.1. GCC Growth Factors Market Outlook, by Product Type, 2020-2033
    • 8.4.2. GCC Growth Factors Market Outlook, by Application, 2020-2033
    • 8.4.3. GCC Growth Factors Market Outlook, by End User, 2020-2033
    • 8.4.4. South Africa Growth Factors Market Outlook, by Product Type, 2020-2033
    • 8.4.5. South Africa Growth Factors Market Outlook, by Application, 2020-2033
    • 8.4.6. South Africa Growth Factors Market Outlook, by End User, 2020-2033
    • 8.4.7. Egypt Growth Factors Market Outlook, by Product Type, 2020-2033
    • 8.4.8. Egypt Growth Factors Market Outlook, by Application, 2020-2033
    • 8.4.9. Egypt Growth Factors Market Outlook, by End User, 2020-2033
    • 8.4.10. Nigeria Growth Factors Market Outlook, by Product Type, 2020-2033
    • 8.4.11. Nigeria Growth Factors Market Outlook, by Application, 2020-2033
    • 8.4.12. Nigeria Growth Factors Market Outlook, by End User, 2020-2033
    • 8.4.13. Rest of Middle East Growth Factors Market Outlook, by Product Type, 2020-2033
    • 8.4.14. Rest of Middle East Growth Factors Market Outlook, by Application, 2020-2033
    • 8.4.15. Rest of Middle East Growth Factors Market Outlook, by End User, 2020-2033
  • 8.5. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Company Vs Segment Heatmap
  • 9.2. Company Market Share Analysis, 2025
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Lonza Group AG
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Developments
    • 9.4.2. Thermo Fisher Scientific Inc.
    • 9.4.3. Merck KGaA
    • 9.4.4. Hoffmann-La Roche Ltd.
    • 9.4.5. Applied Biological Materials (abm), Inc.
    • 9.4.6. Abcam plc
    • 9.4.7. GE Healthcare
    • 9.4.8. Cell Signaling Technology, Inc.
    • 9.4.9. Meridian Bioscience Inc.
    • 9.4.10. Sartorius CellGenix GmbH

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!